Biomade Technology
Biomade
Technology is an independent research institute that converts scientific
knowledge into applications which contribute to an improved quality
of life. In this process we have developed a set of coherent
proprietary technologies centered on protein-based bio-nanotechnology. We are
applying them to a variety of issues such as therapeutic peptides and proteins, artificial
membrane systems and cell growth matrices
for tissue and organ engineering.
Investors have recognized the power and validity of our method,
resulting in the launch in 2007 of Mucosis B.V., a
Biomade spin-out company focused on the development of mucosal vaccines
Given the current economic
climate, we are to concentrating all of our resources on two of
our most advanced technologies, therapeutic protein stabilization and
cell growth matrices, which have been incorporated into two new Biomade
spin-out companies, LanthioPep BV and Nano-FM BV, respectively.
This
project is also financed by the European Union (European Regional Development
Fund - ERDF)
